A review of multi-omics approaches towards understanding late onset and progressive glaucomatous neuropathies
Annals of Eye Science · 2026-03 · 11 · 8-8
DOI: 10.21037/aes-25-60 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Eye Science, 2026-03. Verfasst von Guoqiang Zhu und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Glaucoma and secondary glaucoma are two late-onset and progressive optic neuropathies characterized by progressive optic nerve damage resulting from the loss of retinal ganglion cells (RGCs) and their axons which ultimately manifest as visual field defects. Intraocular pressure (IOP) elevation due to impeded aqueous humor (AH) outflow is found frequently associated with glaucoma, and IOP lowering is usually concomitant with preservation or retention of visual function. Current limitations in glaucoma diagnosis and therapy include a lack of diagnostic and/or susceptibility biomarkers, as well as heterogeneity in the rate of disease progression and treatment efficacy between patients. Rapid analytical advancements in different omics (genome, transcriptome, proteome, lipidome, and metabolome) have provided new avenues to identify biomarkers and drug therapy targets. However, limitations in single-omics studies—such as variance in preparation and analysis methods, incomplete databases used for annotation of molecular components, and limited clinical translatability due to the use of animal models—necessitate multi-omic integration for mutual validation and expansion upon existing knowledge. Our review outlines advancements in glaucoma through different omic studies, demonstrates omics integration using AH datasets of control and glaucoma patients, and discusses current obstacles in multi-omic integration such as standardization across systems and omes and inherent limitations in knowledge- and data-driven approaches to network building. Ultimately, we propose that multi-omics may help expand our understanding of pathological mechanisms in all forms of glaucoma and other late-onset progressive neurodegenerative diseases, advancing discoveries for better interventions.
Zitieren
APA
Zhu, G., Volante, V. S., Gupta, K., Liu, W., & Bhattacharya, S. K. (2026). A review of multi-omics approaches towards understanding late onset and progressive glaucomatous neuropathies. Annals of Eye Science, 11, 8-8. https://doi.org/10.21037/aes-25-60
Vancouver
Zhu G, Volante VS, Gupta K, Liu W, Bhattacharya SK. A review of multi-omics approaches towards understanding late onset and progressive glaucomatous neuropathies. Annals of Eye Science. 2026;11:8-8. doi:10.21037/aes-25-60
BibTeX
@article{Zhu2026,
author = {Zhu, Guoqiang and Volante, Vernon S. and Gupta, Khyati and Liu, Wenjing and Bhattacharya, Sanjoy K.},
title = {A review of multi-omics approaches towards understanding late onset and progressive glaucomatous neuropathies},
journal = {Annals of Eye Science},
year = {2026},
volume = {11},
pages = {8--8},
doi = {10.21037/aes-25-60}
}
EUVIMED